View in EDS HTML Full Text PDF Full Text

Incidence and prognostic impact of HER2‐positivity loss after dual HER2‐directed neoadjuvant therapy for HER2+ breast cancer.

Saved in:
Bibliographic Details
Title: Incidence and prognostic impact of HER2‐positivity loss after dual HER2‐directed neoadjuvant therapy for HER2+ breast cancer.
Authors: LeVee, Alexis1,2 (AUTHOR), Spector, Kellie1,3 (AUTHOR), Larkin, Brigid1 (AUTHOR), Dezem, Felipe4 (AUTHOR), Plummer, Jasmine4 (AUTHOR), Dadmanesh, Farnaz5 (AUTHOR), Patil, Sujata6 (AUTHOR), McArthur, Heather L.1,7 (AUTHOR) heather.mcarthur@utsouthwestern.edu
Source: Cancer Medicine. May2023, Vol. 12 Issue 9, p10647-10659. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20457634
DOI:10.1002/cam4.5817